Volume 18 - Issue 2 - February, 2006
Insights
Commentary
08/01/2008
The percutaneous treatment of bifurcation lesions remains suboptimal. A frequent problem, accounting for 10–20% of coronary lesions undergoing percutaneous coronary intervention (PCI), the bifurcation is plagued by acute technical challenges,...
The percutaneous treatment of bifurcation lesions remains suboptimal. A frequent problem, accounting for 10–20% of coronary lesions undergoing percutaneous coronary intervention (PCI), the bifurcation is plagued by acute technical challenges,...
The percutaneous treatment of...
08/01/2008
Journal of Invasive Cardiology
Feature
Original Contribution
08/01/2008
Silvio Zalc, MD, Pedro A. Lemos, MD, Antonio Esteves, MD, Expedito E. Ribeiro, MD, Pedro Horta, MD, Jose C. Nicolau, MD, Jose A.F. Ramires, MD, Marc Cohen, MD, Eulogio E. Martinez, MD
Silvio Zalc, MD, Pedro A. Lemos, MD, ...
Low-molecular weight heparin (LMWH), especially enoxaparin, and unfractionated heparin (UFH), is recommended in the early medical management of acute coronary syndromes.1,2 Compared to intravenous UFH, subcutaneous LMWH has a more predictable...
Low-molecular weight heparin (LMWH), especially enoxaparin, and unfractionated heparin (UFH), is recommended in the early medical management of acute coronary syndromes.1,2 Compared to intravenous UFH, subcutaneous LMWH has a more predictable...
Low-molecular weight heparin...
08/01/2008
Journal of Invasive Cardiology